Detalhe da pesquisa
1.
Reappraising the Diagnostic Accuracy of Post-Treatment Whole-Body Scans for Differentiated Thyroid Carcinoma.
Horm Metab Res;
52(12): 834-840, 2020 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32750721
2.
Patterns of radioiodine use for differentiated thyroid carcinoma in Brazil: insights and a call for action from a 20-year database.
Arch Endocrinol Metab;
64(6): 824-832, 2021 Nov 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33085995
3.
Impact of the updated TNM staging criteria on prediction of persistent disease in a differentiated thyroid carcinoma cohort.
Arch Endocrinol Metab;
63(1): 5-11, 2019 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30864625
4.
Neoadjuvant Multikinase Inhibitor in Patients With Locally Advanced Unresectable Thyroid Carcinoma.
Front Endocrinol (Lausanne);
10: 712, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31695679
5.
Dynamic Risk Stratification in the Follow-Up of Children and Adolescents with Differentiated Thyroid Cancer.
Thyroid;
28(10): 1285-1292, 2018 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30129889
6.
Impact of the updated TNM staging criteria on prediction of persistent disease in a differentiated thyroid carcinoma cohort
Arch. endocrinol. metab. (Online);
63(1): 5-11, Jan.-Feb. 2019. tab, graf
Artigo
em Inglês
| LILACS
| ID: biblio-989299